人工智能指数涨超3%，关注人工智能ETF（159819）、科创人工智能ETF（588730）等投资价值

Group 1 - The article discusses various ETFs tracking innovative pharmaceutical indices in Hong Kong and mainland China, highlighting their focus on leading companies in the innovative drug sector [1] - The Hang Seng Innovative Drug ETF tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Index, which consists of no more than 40 stocks involved in innovative drug research, development, and production [1] - The Hong Kong Stock Connect Medical ETF tracks the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index, comprising 50 stocks from the medical device, biopharmaceutical, chemical drug, and other healthcare sectors [1] Group 2 - The E Fund Innovative Drug ETF tracks the CSI Innovative Drug Industry Index, focusing on leading companies in the A-share innovative drug sector, consisting of no more than 50 stocks involved in innovative drug research and development [1] - The performance metrics of these indices show varying changes, with the Hang Seng Innovative Drug ETF experiencing a decline of 0.1% and the Hong Kong Stock Connect Medical ETF increasing by 0.7% [1] - The E Fund Innovative Drug ETF has seen an increase of 2.7% since its inception, with a rolling price-to-earnings ratio of 54.9 times and an 83.7% valuation percentile since its launch [1]